Empresa Merrimack Pharmaceuticals Inc Nasdaq
Acciones
US5903281005
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 01/01/93 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/01/04 |
Investor Relations Contact | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 01/01/04 |
Director/Board Member | 45 | 19/09/19 | |
Ulrik Nielsen
FOU | Founder | 52 | 01/01/93 |
Director/Board Member | 46 | 19/09/19 | |
Ana Radeljevic
BRD | Director/Board Member | 44 | 06/06/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 14 531 760 | 14 355 601 ( 98,79 %) | 0 | 98,79 % |
Información de la empresa
Merrimack Pharmaceuticals, Inc.
One Broadway 14th Floor
02142, Cambridge
+
http://www.merrimackpharma.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,03 % | 48,16 mil M | |
-0,10 % | 41,73 mil M | |
+43,45 % | 41,03 mil M | |
-5,26 % | 28,77 mil M | |
+11,48 % | 25,59 mil M | |
-22,74 % | 18,96 mil M | |
+9,06 % | 12,92 mil M | |
+30,01 % | 12,03 mil M | |
-1,51 % | 11,77 mil M |